US Patent Issued to Yale University on Sept. 16 for "CXCR5 antagonists and methods of treating diseases or disorders using same" (Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,927, issued on Sept. 16, was assigned to Yale University (New Haven, Conn.).

"CXCR5 antagonists and methods of treating diseases or disorders using same" was invented by Elias Lolis (Westport, Conn.), Francine Foss (Hamden, Conn.), Demetrios Braddock (Guilford, Conn.), Yulia Surovtseva (Branford, Conn.), Christopher Fanger (Bolton, Mass.), Mark Plummer (Westbrook, Conn.), Denton Hoyer (West Haven, Conn.) and Elizabeth Spencer (Southbury, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compounds, and compositions comprising such compounds, that can be used to treat CXCR5-expressing cancers, especially angioimmunoblastic ...